Kresmion

Kresmion signals archive

176 cross-asset signals fired across commodity, crypto, equity, forex, macro. See also the Kresmion brief for 2026-05-14.

commodity (23)

  • criticalfutures_volume_spikeKC=F

    Coffee volume spike - 12.3× the 20-day average (12,529 vs 1,018 avg)

  • criticalfutures_volume_spikeSI=F

    Silver volume spike - 28.6× the 20-day average (52,978 vs 1,854 avg)

  • criticalfutures_volume_spikeZC=F

    Corn volume spike - 3.2× the 20-day average (260,137 vs 80,742 avg)

  • criticalfutures_volume_spikeCC=F

    Cocoa volume spike - 12.3× the 20-day average (17,160 vs 1,395 avg)

  • criticalfutures_volume_spikeZS=F

    Soybeans volume spike - 5.3× the 20-day average (251,437 vs 47,515 avg)

  • criticalfutures_volume_spikeGC=F

    Gold volume spike - 183.5× the 20-day average (99,841 vs 543 avg)

  • criticalfutures_volume_spikePL=F

    Platinum volume spike - 315.5× the 20-day average (15,506 vs 49 avg)

  • criticalfutures_volume_spikeHG=F

    Copper volume spike - 19.1× the 20-day average (43,543 vs 2,274 avg)

  • criticalfutures_volume_spikeZW=F

    Wheat volume spike - 6.7× the 20-day average (116,857 vs 17,449 avg)

  • criticalNET_LONG_EXTREMENG=F

    NATURAL GAS - speculators net long (+3.0σ vs 52w mean) - contrarian bear signal

  • highfutures_volume_spikeCT=F

    Cotton volume spike - 2.6× the 20-day average (37,006 vs 14,203 avg)

  • highfutures_price_gapKC=F

    Coffee bear 7.2% vs prior close ($296.25 → $274.90)

  • highosint_energy_eventOIL

    OSINT: German 10‑yr Yield Slightly Falls, Still Near Multi‑Year Highs

  • highosint_energy_eventOIL

    OSINT: Cost of Living Surges 106% Since 2001, Says Fortune

  • highweather_supply_riskCL=F

    Saudi Arabia (Dhahran): drought conditions detected - potential oil supply impact

  • highosint_energy_eventOIL

    OSINT: Guatemala FM says democracy owed to Venezuelan people

  • mediumfutures_price_gapCT=F

    Cotton bear 4.0% vs prior close ($86.81 → $83.33)

  • mediumfutures_price_gapSI=F

    Silver bear 5.5% vs prior close ($88.89 → $84.01)

  • mediumfutures_price_gapPL=F

    Platinum bear 5.4% vs prior close ($2,187.10 → $2,069.70)

  • medcommodity_moveOIL

    Oil +1.14% - significant rally

  • medNET_LONG_EXTREMEHG=F

    COPPER - speculators net long (+2.1σ vs 52w mean) - contrarian bear signal

  • medcommodity_moveOIL

    Oil -1.18% - significant selloff

  • lowfutures_price_gapRB=F

    RBOB Gasoline bear 3.8% vs prior close ($3.62 → $3.48)

equity (138)

  • highFDA_APPROVALPFE

    FDA approves CAVERJECT IMPULSE (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves IDAMYCIN PFS (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves IDAMYCIN PFS (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves ZITHROMAX (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves CAVERJECT IMPULSE (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves IDAMYCIN PFS (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves ZITHROMAX (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves LITFULO (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves LINCOCIN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves LINCOCIN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves LINCOCIN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves TIKOSYN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves TIKOSYN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves drug (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves TIKOSYN (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves ZITHROMAX (Pfizer) - new revenue stream

  • highFDA_APPROVALPFE

    FDA approves CAVERJECT IMPULSE (Pfizer) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALLLY

    FDA approves drug (Lilly) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves SUCRALFATE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves OZURDEX (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves OZURDEX (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves OZURDEX (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves FETZIMA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves FETZIMA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves FETZIMA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves SUCRALFATE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves SUCRALFATE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves ULTANE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves ULTANE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CANASA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CANASA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CANASA (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves AVYCAZ (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves AVYCAZ (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves AVYCAZ (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves ULTANE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves drug (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CRINONE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CRINONE (AbbVie) - new revenue stream

  • highFDA_APPROVALABBV

    FDA approves CRINONE (AbbVie) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • highFDA_APPROVALABT

    FDA approves drug (Abbott) - new revenue stream

  • medtrend_spikeAMP

    Ameriprise Financial search volume spiked +83 pts - unusual interest

  • medjobs_anomalyTSCO

    TSCO job postings down -99% WoW - potential restructuring

  • medtrend_spikeAMGN

    Amgen search volume spiked +81 pts - unusual interest

  • medtrend_spikeGOOGL

    Alphabet Inc. (Class A) search volume spiked +100 pts - unusual interest

  • medrsi_crossNVDA

    NVDA RSI 70.3 - overbought (crossed above 70)

  • medEARNINGS_BEATAMAT

    Q2-2026: Beat consensus by 5.4% - EPS $2.86 vs $2.7128 estimate

  • medtrend_spikeCHRW

    C.H. Robinson search volume spiked +78 pts - unusual interest

  • medcongress_clusterTDG

    1 congress member filed 5 trades in TDG: net buying (5B/0S)

  • medosint_eventTECH

    OSINT: Applied Materials Beats Q2 Estimates on EPS and Revenue

  • medtrend_spikeINVH

    Invitation Homes search volume spiked +69 pts - unusual interest

  • medtrend_spikeALGN

    Align Technology search volume spiked +71 pts - unusual interest

  • medjobs_anomalyCNC

    CNC job postings down -91% WoW - potential restructuring

  • medtrend_spikeAMP

    Ameriprise Financial search volume spiked +83 pts - unusual interest

  • medjobs_anomalyTSCO

    TSCO job postings down -97% WoW - potential restructuring

  • medtrend_spikeAMGN

    Amgen search volume spiked +81 pts - unusual interest

  • medtrend_spikeMO

    Altria search volume spiked +78 pts - unusual interest

  • medtrend_spikeGOOGL

    Alphabet Inc. (Class A) search volume spiked +100 pts - unusual interest

  • medrsi_crossNVDA

    NVDA RSI 70.1 - overbought (crossed above 70)

  • medtrend_spikeCF

    CF Industries search volume spiked +80 pts - unusual interest

  • medcongress_clusterTDG

    1 congress member filed 5 trades in TDG: net buying (5B/0S)

  • medjobs_anomalyCNC

    CNC job postings down -91% WoW - potential restructuring

  • medtrend_spikeAMP

    Ameriprise Financial search volume spiked +83 pts - unusual interest

  • medjobs_anomalyTSCO

    TSCO job postings down -97% WoW - potential restructuring

  • medtrend_spikeAMGN

    Amgen search volume spiked +81 pts - unusual interest

  • medtrend_spikeGOOGL

    Alphabet Inc. (Class A) search volume spiked +100 pts - unusual interest

  • medtrend_spikeMO

    Altria search volume spiked +78 pts - unusual interest

  • medtrend_spikeCF

    CF Industries search volume spiked +80 pts - unusual interest

  • medcongress_clusterTDG

    1 congress member filed 5 trades in TDG: net buying (5B/0S)

  • medosint_eventTECH

    OSINT: Nvidia becomes world’s second‑largest asset, overtaking silver

  • medjobs_anomalyCNC

    CNC job postings down -91% WoW - potential restructuring

  • medtrend_spikeAMP

    Ameriprise Financial search volume spiked +83 pts - unusual interest

  • medjobs_anomalyTSCO

    TSCO job postings down -97% WoW - potential restructuring

  • medtrend_spikeAMGN

    Amgen search volume spiked +81 pts - unusual interest

  • medtrend_spikeGOOGL

    Alphabet Inc. (Class A) search volume spiked +100 pts - unusual interest

  • medtrend_spikeMO

    Altria search volume spiked +78 pts - unusual interest

  • medcongress_clusterTDG

    1 congress member filed 5 trades in TDG: net buying (5B/0S)

  • medtrend_spikeCF

    CF Industries search volume spiked +80 pts - unusual interest

crypto (11)

  • highetf_flow_anomalyETH

    ETH ETF inflow of $134M - institutional buying

  • highetf_flow_anomalyETH

    ETH ETF inflow of $134M - institutional buying

  • highetf_flow_anomalyETH

    ETH ETF inflow of $134M - institutional buying

  • meddex_volume_liquidityETH

    ETH DEX volume/liquidity ratio elevated (0.57x) - strong on-chain trading activity

  • meddex_volume_liquiditySOL

    SOL DEX volume/liquidity ratio elevated (1.52x) - strong on-chain trading activity

  • medosint_eventCRYPTO

    OSINT: Solana's P-Token Upgrade Cuts Transfer Compute Costs Over 95%

  • meddex_volume_liquidityETH

    ETH DEX volume/liquidity ratio elevated (0.50x) - strong on-chain trading activity

  • medrsi_crossSOL

    SOL RSI 70.3 - overbought (crossed above 70)

  • meddex_volume_liquiditySOL

    SOL DEX volume/liquidity ratio elevated (1.22x) - strong on-chain trading activity

  • medosint_eventCRYPTO

    OSINT: Nvidia becomes world’s second‑largest asset, overtaking silver

  • meddex_volume_liquiditySOL

    SOL DEX volume/liquidity ratio elevated (1.24x) - strong on-chain trading activity

forex (2)

  • meddxy_moveDXY

    DXY +0.40% - dollar strength signal

  • meddxy_moveDXY

    DXY +0.30% - dollar strength signal

macro (2)

  • medvix_spikeVIX

    VIX at 18.0 - CAUTION territory

  • medNFCI_RELIEFMARKET

    Financial conditions loosening - NFCI at -0.52, liquidity supportive